Category: Cost Alert

AHIP statement on Harvoni

America’s Health Insurance Plans (AHIP) Spokesman Brendan Buck released the following statement today after Gilead Sciences announced its newly approved hepatitis C drug Harvoni will be priced at $94,500 for a course of treatment. Continue reading

Posted in: Cost Alert, Health Care Costs

Moment of Truth: Gilead Comes to a Pricing Decision Point

The eyes of the health care world – and prime time TV audiences – are focused this week on the high prices of many pharmaceutical drugs. And one looming decision will tell us whether the tide has turned in favor of sustainable pricing – or whether drugmakers still have their heads in the sand. Continue reading

Posted in: Cost Alert, Health Care Costs

Consumer Reports: What’s to blame for soaring health care costs

Consumers are angry over outrageous sky-high health care costs, and rightfully so. But what’s to blame for this health care cost outrage? Consumer Reports gives us some answers. Continue reading

Posted in: Cost Alert

Chart of the day: Anger at outrageous health care costs

Health care costs are increasing at unsustainable and unaffordable rates, and consumers are sounding the alarm. They’re fed up with the soaring prices for medical services, as evidenced by a recent Consumer Reports survey that’s aptly titled The Anger Index. Continue reading

Posted in: Cost Alert, Health Care Costs

Cover story: Rising drug prices

With a full pipeline of new specialty drugs and ever-rising prices, the drug price problem has grown into a cover story at the Washington Examiner. Continue reading

Posted in: Cost Alert, Health Care Costs

Lower the Price

Following today’s earnings report released by Gilead, the manufacturer of Sovaldi, AHIP Spokesman Brendan Buck released the following statement: “It’s time to lower the price of Sovaldi. While it was a blockbuster quarter for Gilead, people who can’t access the drug because of its price didn’t fare nearly as well. Health plans and government programs are covering the vast majority of the cost of Sovaldi, but the price being charged continues to put the drug out of reach for too [...]

Posted in: Cost Alert, Health Care Costs, Uncategorized

Wow, this drug is really expens — Look! A squirrel!!

For years, the pharmaceutical industry has had a pretty simple strategy for discussing the prices it charges for its drugs: don’t. Continue reading

Posted in: Cost Alert, Health Care Costs

A Single Drug: 8% Higher Premiums for Seniors on Medicare

We’ve discussed the astronomically priced hepatitis C drug, Sovaldi, the concern that this is the new normal, and the outrage its pricing has sparked. Continue reading

Posted in: Cost Alert, Health Care Costs

Chart of the Day: Twelve of the Most Expensive Specialty Drugs

“Since 2007, the cost of many of the brand names associated with those drugs has skyrocketed, according to a recent Bloomberg News analysis, with prices in many cases doubling and tripling. ‘While the consumer price index rose just 12 percent in the period,’ Bloomberg reported, ‘one diabetes drug quadrupled in price and another rose by 160 percent.’” Continue reading

Posted in: Cost Alert, Health Care Costs

Chart of the Day: California’s Projected Spending on Sovaldi vs. Spending on Education

“California, for example, might have to spend more on buying Sovaldi for its Medicaid beneficiaries than it currently does on all K-12 and higher education.” Continue reading

Posted in: Cost Alert, Health Care Costs, Issue Alert